[Antiaggregative activity of the arterial and venous walls in arteriosclerosis].
D000328:Adult; D000368:Aged; D001158:Arteries / Q000378:metabolism*; D001161:Arteriosclerosis / Q000209:etiology / Q000503:physiopathology*; D011464:Epoprostenol / Q000172:deficiency / Q000502:physiology*; D005260:Female; D005343:Fibrinolytic Agents; D006801:Humans; D066298:In Vitro Techniques; D008297:Male; D008875:Middle Aged; D010974:Platelet Aggregation; D011453:Prostaglandins / Q000502:physiology*; D014680:Veins / Q000378:metabolism*
D005343:Fibrinolytic Agents; D011453:Prostaglandins; D011464:Epoprostenol
Aktywność antyagregacyjna sciany tétnic i zył u chorych z miazdzyca.